• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Subscribe NOW for the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation Alert!

Pharma Sources InsightJune 18, 2021

Tag: Pharma Sources Insight , PharmaSources , Subscribe

2021第三期封面带二维码.jpg


About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers and medical product suppliers in China which further affect the world. 

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China. View all the issues of PSI from here.


Subscribe NOW for the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation Alert!

Click and Subscribe Now


Previous:Risk of Covid plummets 21 days after first vaccine dose, analysis suggests

Next:Immunicum Announces Results of Directed Share Issue

Related News

Charting the Course: A Deep Dive into Pharmaceutical Product Lifecycle Management

Shruti TalashiNovember 21, 2024

At every stage of the product lifecycle, pharmaceutical companies are subject to strict regulations and must maintain compliance with local governing bodies.

Globalization of drugs -A Double-Edged Sword with Room for Improvement

Shruti TalashiNovember 20, 2024

Japanese Pharmaceutical Market & Registration Strategies- Part 2

Deepak HegdeNovember 12, 2024

Subscribe NOW for the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation Alert! | Pharmasources.com

Japanese Pharmaceutical Market & Registration Strategies – Part 1

Deepak HegdeNovember 12, 2024

The article provides an outline of characteristics、Regulatory bodies、 Pricing、Reimbursement、the process of registering an innovative drug and generic drugs in Japan.

You may like
More>>

PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins
CEFRADINE cephalosporins

CEFRADINE cephalosporins
CEFADROXIL cephalosporins

CEFADROXIL cephalosporins
CEFIXIME cephalosporins

CEFIXIME cephalosporins
CEFATHIAMIDINE cephalosporins

CEFATHIAMIDINE cephalosporins
CEFMINOX SODIUM cephalosporins

CEFMINOX SODIUM cephalosporins
CEFOXITIN SODIUM cephalosporins

CEFOXITIN SODIUM cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service